On January 4, 2016, the US Food and Drug Administration (FDA) announced a big change for transvaginal mesh. Previously classified as a Class II medical device, the FDA reclassified transvaginal…
Read More
The US FDA approved Caldera Medical’s latest version of Vertessa Lite mesh in June 2015, even though there is ongoing controversy about the safety of these type of devices. Caldera…
C.R. Bard, a manufacturer of medical devices used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), recently settled a vaginal mesh lawsuit. Selected as a bellwether case,…
Boston Scientific, the company behind such products as Pinnacle transvaginal mesh, must pay $26.7 million in a transvaginal mesh lawsuit in Miami. After a deliberation period lasting only a few…
As mandated by the U.S. Food and Drug Administration (FDA), American Medical Systems (AMS) has started its transvaginal mesh study by enrolling its first participant. The transvaginal mesh manufacturer announced…
A report published in May 2014 by the Minneapolis newspaper, Star Tribune, highlighted the risks of using transvaginal mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI)….
Health Canada, the Canadian equivalent of the U.S. Food and Drug Administration (FDA), issued an announcement in early May 2014 with new information on transvaginal mesh. Their announcement pertained specifically…
The U.S. Food & Drug Administration (FDA) announced in a news release dated April 29, 2014 that it would put forth two orders relating to transvaginal mesh used to treat…
After experiencing complications with their transvaginal mesh implants, two New Zealand women are reaching out to their government for assistance. One of the women, Carmel Berry, explained how she had…
Transvaginal mesh is used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). As a national law firm representing individuals who believe their injuries (stem) from…